ホーム › 乳がん › アイオワ州 › Cedar Rapids
Cedar Rapids、IAにおける乳がんの臨床試験
Cedar Rapidsとその周辺地域（約30マイル以内）の拠点で、乳がんに関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
被験者募集中第1/2相
- University of Iowa Hospitals and Clinics, Iowa City · 25マイル先
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Local Institution - 0065, Iowa City · 25マイル先
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- University of Iowa, Iowa City · 25マイル先
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
被験者募集中第1相
- University of Iowa Hospitals and Clinics, Iowa City · 25マイル先
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25マイル先
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- University of Iowa, Iowa City · 25マイル先
Exercise Oncology Clinic Pilot Feasibility Trial
被験者募集中
- University of Iowa Health Care, Iowa City · 25マイル先
Breast Cancer PSMA PET
被験者募集中早期第1相
- University of Iowa Healthcare, Iowa City · 25マイル先
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- Saint Luke's Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- University of Iowa, Iowa City · 25マイル先
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
被験者募集中第4相
- Iowa Holden Comprehensive Cancer Center, Iowa City · 25マイル先
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
被験者募集中第1相
- University of Iowa Health Care, Iowa City · 25マイル先
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Saint Luke's Hospital, Cedar Rapids
Quantitative MRI Assessment of Breast Cancer Therapy Response
被験者募集中観察研究
- University of Iowa, Iowa City · 25マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Iowa City · 25マイル先
他の都市における乳がんの試験
- New York City, NY134件の研究
- Houston, TX126件の研究
- Boston, MA111件の研究
- Nashville, TN80件の研究
- Los Angeles, CA72件の研究
- Edison, NJ68件の研究
- St. Louis, MO64件の研究
- Durham, NC63件の研究
- Queens, NY63件の研究
- Chicago, IL58件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
Cedar Rapidsにおける他の研究
- 非小細胞肺癌20件の研究
- 急性骨髄性白血病16件の研究
- がん（全種類）15件の研究
- 多発性骨髄腫15件の研究
- 肺がん14件の研究
- 大腸癌13件の研究
- 前立腺がん12件の研究
- 頭頸部扁平上皮癌12件の研究
- 悪性黒色腫10件の研究
- 脳卒中10件の研究
- 転移性癌9件の研究
- 子宮内膜がん9件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。